HOME    CONTACT    DISCLAIMER    SEARCH   
Home
About Us

Cilian AG is an innovative biotechnology enterprise, which uses the singular abilities of Ciliates, a new class of production organisms, for the industrial production of therapeutic proteins.

» More
 
Scientific Background

Cilian uses Ciliates of the species Tetrahymena for the production of therapeutic proteins. Tetrahymena is a unicellular, apathogenic eukaryotic micro-organism, and a very common organism in fresh water like ponds and lakes.

» More
 
Product

Ciliates of the genus Tetrahymena naturally secrete large quantities of enzymes, so-called lysosomal acid hydrolases, into the surrounding culture medium.

» More
News

10.10.2011
Press release
"Cilian AG reached major milestone with the production and in vivo testing of recombinant flu viral protein as potential vaccine against Influenza"
» more

10.08.2011
Press release
"Cilian AG granted two European Patents for Ciliate based..."
» more

22.02.2011
BMC Biotechnology
"Cilian publishes article in BMC Biotechnology ..."
» more

institutional member of BioMed Central